How much funding has Sparrow Pharmaceuticals raised?

Sparrow Pharmaceuticals has raised $217.0M in total funding, most recently a Series B round.

Who are Sparrow Pharmaceuticals's investors?

Sparrow Pharmaceuticals's investors include OrbiMed, RA Capital Management, Forbion Capital Partners, RiverVest Venture, US Venture Partners.

When was Sparrow Pharmaceuticals founded?

Sparrow Pharmaceuticals was founded in 2021.

Where is Sparrow Pharmaceuticals headquartered?

Sparrow Pharmaceuticals is headquartered in Portland, Oregon, United States.

What industry is Sparrow Pharmaceuticals in?

Sparrow Pharmaceuticals operates in Biotech.

How many employees does Sparrow Pharmaceuticals have?

Sparrow Pharmaceuticals has 11-50 employees.

Sparrow Pharmaceuticals

Targeted cardiometabolic therapeutics

Portland, United States · Founded 2021 · $217.0M raised

Biotech

Headquarters: Portland, Oregon
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: sparrowpharma.com
Total Funding: $217.0M
Last Round: $95.0M Series BSep 2025
Rounds: 4

About

Leveraging scientific insights into the intracellular regulation of cortisol, Sparrow is pioneering a precision approach to cardiometabolic disease. Their lead candidate, clofutriben, is a highly potent HSD-1 inhibitor designed to reduce elevated intracellular cortisol, addressing impaired glucose control in millions of patients with difficult-to-control type 2 diabetes.

Summary

Sparrow Pharmaceuticals is a Biotech company based in Portland, United States, founded in 2021. It has raised $217.0M in total across 4 rounds, most recently a $95.0M Series B round in Sep 2025. Investors include OrbiMed, RA Capital Management and Forbion Capital Partners.

LinkedIn X (Twitter)